Physician profile
Codi Crabtree
NPI 1831833847
$2,346.95
in general payments reported to CMS, 2019-2025
24 companies · $518 in 2025
The $518 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $91.24 · 2023: $399 · 2024: $1,339 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,425 · Travel and Lodging: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,424.85 |
| Travel and Lodging | $830.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,254.66 | 2024-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Smith+Nephew, INC. | $232.86 | 2024-2025 | Collagenase Santyl, Grafix |
| Novo Nordisk INC | $89.98 | 2023 | Rybelsus, Ozempic, Wegovy |
| Solventum Corporation | $89.37 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, 3m Cavilon |
| Merck Sharp & Dohme LLC | $82.20 | 2022-2023 | Verquvo, Belsomra, Dificid |
| Amgen INC. | $65.33 | 2022-2023 | Otezla, Repatha, Evenity |
| Paratek Pharmaceuticals, INC. | $65.23 | 2024-2025 | Nuzyra |
| Mimedx Group, INC. | $59.05 | 2025 | |
| Abbvie INC. | $51.49 | 2023-2024 | |
| Lilly USA, LLC | $45.54 | 2022-2023 | Mounjaro, Trulicity, Emgality |
| Pfizer INC. | $42.25 | 2023 | |
| Urgo Medical North America, LLC | $41.02 | 2025 | Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Currax Pharmaceuticals LLC | $28.49 | 2023 | Contrave, Nexlizet, Nexletol |
| Bsn Medical INC | $25.86 | 2025 | |
| Reprise Biomedical, INC. | $23.41 | 2025 | Miro3d |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $22.29 | 2023 | |
| Reapplix INC. | $20.43 | 2025 | 3c Patch Kit - Box |
| Biohaven Pharmaceutical Holding Company LTD. | $19.17 | 2022 | |
| Xeris Pharmaceuticals, INC. | $17.91 | 2023 | Gvoke Hypopen |
| Exact Sciences Corporation | $15.47 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.86 | 2023 | Xifaxan, Trulance |
| Convatec INC. | $14.66 | 2025 | |
| Hartmann USA, INC. | $13.38 | 2024 | Zetuvit Plus 10x10 P10 |
| Novartis Pharmaceuticals Corporation | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Codi Crabtree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.